Previous 10 | Next 10 |
Nes Ziona, Israel, June 01, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 8:00 AM ET....
Thinly traded nano cap Enlivex Therapeutics (NASDAQ: ENLV ) is up 7% premarket on light volume in reaction to new positive data from a Phase 1b clinical trial evaluating off-the-shelf immunotherapy Allocetra in patients with sepsis. More news on: Enlivex Therapeutics Ltd., ...
- Exploratory endpoint analyses demonstrated Allocetra’s potential therapeutic effect in resolving cytokine storms in patients with heterogenous pathologies Nes Ziona, Israel, May 28, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunother...
Nes Ziona, Israel, May 07, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that an investigator-initiated multi-center Phase II clinical trial of Allocetra TM (formerly referred to as off-the-shelf Allocetra TM ) ...
SCWorx (NASDAQ: WORX ) +171% on order for 2M COVID-19 blood tests. More news on: SCWorx Corp., Can-Fite BioPharma Ltd., Independence Contract Drilling, Inc., Stocks on the move, , Read more ...
Nes Ziona, Israel, April 13, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the Israel Innovation Authority (IIA) selected the Company’s planned COVID-19 and sepsis clinical programs to receive, in th...
Following up from interim results announced in November 2019, Enlivex Therapeutics ( ENLV -21.5% ) reports final data from a Phase 1b clinical trial evaluating Allocetra-OTS, an off-the-shelf immunotherapy designed to avert excessive and life-threatening immune response called c...
Biomerica (NASDAQ: BMRA ) +133% on advancement of rapid coronavirus test. More news on: Biomerica, Inc., IMV Inc., Vaxart, Inc., Stocks on the move, , Read more ...
– Final Analysis Comparing 10 Allocetra TM -Treated Patients with 37 Matched Controls Showed Significant Positive Responses in State of Organ Failure, ICU Hospitalization and Mortality in a Highly Fragile and Extremely Difficult to Treat Population with Severe Sepsis – Nes Z...
Tiziana Life Sciences PLC (NASDAQ: TLSA ) +162% on potential coronavirus treatment . More news on: Tiziana Life Sciences PLC, Phio Pharmaceuticals Corp., Inovio Pharmaceuticals, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NASDAQ Market:
Enlivex Therapeutics Ltd. Website:
• First study of Allocetra TM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis 1 , and has limited treatment options Nes-Ziona, Israel, July 23, 2024 (GLOB...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...